Issuer: Novo Nordisk Finance (Netherlands) B.V.

Guarantor: Novo Nordisk A/S

Amount: EUR 650 million

Coupon: 0%

Issue date: 4 June 2021

Maturity: 4 June 2024

ISIN: XS2348030268

 

Issuer: Novo Nordisk Finance (Netherlands) B.V.

Guarantor: Novo Nordisk A/S

Amount: EUR 650 million

Coupon: 0.125%

Issue date: 4 June 2021

Maturity: 4 June 2028

ISIN: XS2348030425

 

Issuer: Novo Nordisk Finance (Netherlands) B.V.

Guarantor: Novo Nordisk A/S

Amount: EUR 500 million

Coupon: 0.75%

Issue date: 31 March 2022

Maturity: 31 March 2025

ISIN: XS2441244535

 

Issuer: Novo Nordisk Finance (Netherlands) B.V.

Guarantor: Novo Nordisk A/S

Amount: EUR 500 million

Coupon: 1.125%

Issue date: 31 March 2022

Maturity: 30 September 2027

ISIN: XS2449330179

 

Issuer: Novo Nordisk Finance (Netherlands) B.V.

Guarantor: Novo Nordisk A/S

Amount: EUR 500 million

Coupon: 1.375%

Issue date: 31 March 2022

Maturity: 31 March 2030

ISIN: XS2441247041

Moody's Investors Service
Long-term: A1
Outlook: Stable

S&P Global Ratings
Long-term: AA-
Outlook: Stable

On 20 May 2021, Novo Nordisk A/S established a Euro Medium Term Note programme (the “Programme”) listed on the Euronext Dublin Regulated Market of the Irish Stock Exchange. On 8 June 2022, Novo Nordisk A/S updated the Euro Medium Term Note programme (the “Programme”) listed on the Euronext Dublin Regulated Market of the Irish Stock Exchange.

Base Prospectus

You are not required to provide us with your personal data. If you do not want Novo Nordisk to use your personal data, we will not be able to respond to your request.

  • Contact information (name, address, telephone number, email address)
  • Data concerning your health 

By law, we are allowed to process your personal data if:

  • you gave consent for us to process your personal data. In our contact forms you have to accept this notice to be able to submit your request.
  • The processing can be necessary for our compliance with a legal obligation depending on the type of data you provide

  • Public authorities 
  • Suppliers or vendors that assist our company (e.g., customer services, consultants, IT service providers, financial institutions, law firms)

The level of data protection in certain countries outside the EEA does not conform to the level of data protection for personal data currently applied and enforced within the EEA.

We therefore use the following safeguards, as required by law, to protect your personal data in case of such transfers:

  • The transfer is to a Novo Nordisk entity covered by Novo Nordisk’s Binding Corporate Rules, available here.
  • The destination countries are deemed by the EU Commission to have an adequate level of protection of personal data
  • We have entered into Standard Contractual Clauses for the Transfer of Personal Data to Third Countries. You can get a copy of the Clauses by contacting us as described in the top of this page; 

For as long as needed to provide you with the services requested by you or for as long as required by applicable law.

  • You can get an overview of what personal data we have about you
  • You can get a copy of your personal data in a structured, commonly used and machine-readable format
  • You can get an update or correction to your personal data
  • You can have your personal data deleted or destroyed
  • You can have us stop or limit processing of your personal data
  • If you have given consent for us to process your personal data (see Section 5), you can withdraw your consent at any time. Your withdrawal will not affect the lawfulness of the processing carried out before you withdrew your consent
  • You can submit a complaint about how we process your personal data to a Data Protection Authority.
     

Under applicable law, there may be limits on these rights depending on the specific circumstances of the processing activity. Contact us if you have questions or requests relating to these rights.

Investors

Share price

{{priceData.date}} {{priceData.time}}

{{priceData.currentPrice}} {{priceData.currency}}
Go to stock watch {{priceData.change}} {{priceData.currency}}

Annual Report

Cover page of the Novo Nordisk Annual Report 2022

Annual Report 2022

Download Annual Report